Literature DB >> 8397370

Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.

T Yano1, C A Sander, H M Clark, M V Dolezal, E S Jaffe, M Raffeld.   

Abstract

The primary tumors from 15 untreated patients with Burkitt's lymphoma were analysed for abnormalities in the coding region of the MYC gene by single stranded conformational polymorphism (SSCP) analysis followed by DNA sequencing. Fourteen of the 15 tumors had one or more clonal mutations. Forty one mutations were found in the second exon; only one occurred in the third exon. Seven tumors had mutations that clustered in a region spanning amino acids 38-63. Four of these possessed mutations that altered prolines at positions 57 (3), 60 (1), and 63 (1). Seven tumors were mutated in the central portions of the second exon. These occurred at position 95 (2), position 115 (2), position 137 (1), and position 138 (3). Analysis of the published sequences from five lymphoma cell lines and one primary tumor showed a similar clustering of mutations, with all six having mutations in codons between positions 38-63. The regions where mutations occurred have been associated with a variety of properties, including transcriptional activation and cellular transformation. The number and location of mutations showed no correlation with either chromosome 8 or chromosome 14 breakpoints or with the Epstein-Barr virus positivity of the tumors. This unexpected, frequent occurrence of clustered mutations in the second exon of the MYC gene suggests a role for the mutated MYC proteins in the pathogenesis of Burkitt's lymphoma, possibly through altered interactions of this domain with other cellular factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397370

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 3.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Myc: the beauty and the beast.

Authors:  Amanda R Wasylishen; Linda Z Penn
Journal:  Genes Cancer       Date:  2010-06

Review 6.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

7.  Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

Authors:  Brian K Law; Anna Chytil; Nancy Dumont; Elizabeth G Hamilton; Mary E Waltner-Law; Mary E Aakre; Cassondra Covington; Harold L Moses
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.

Authors:  Chien-Hung Yeh; Marcia Bellon; Joanna Pancewicz-Wojtkiewicz; Christophe Nicot
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

9.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.